Palatin Technologies
PTN
$1.82
Share price
5.81%
Change (1 day)
-22.88%
Change (1 year)
Categories
Palatin Technologies (PTN) - Total debt
Total debt on the balance sheet as of December 2023 : $0.82 M
According to Palatin Technologies's latest financial reports the company's total debt is $0.82 M. A company’s total debt is the sum of all current and non-current debts.
Palatin Technologies - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-06-30 | $1.05 M | -8.93% |
| 2022-06-30 | $1.15 M | -7.87% |
| 2021-06-30 | $1.25 M | -1.09% |
| 2020-06-30 | $1.26 M | 280.34% |
| 2019-06-30 | $0.33 M | -94.7% |
| 2018-06-30 | $6.28 M | -55.52% |
| 2017-06-30 | $14.12 M | -27.67% |
| 2016-06-30 | $19.52 M | 98.23% |
| 2015-06-30 | $9.84 M | |
| 2014-06-30 | $N/A | -100% |
| 2013-06-30 | $0.01 M | -52.81% |
| 2012-06-30 | $0.04 M | -45.29% |
| 2011-06-30 | $0.07 M | 127.1% |
| 2010-06-30 | $0.03 M | -72.08% |
| 2009-06-30 | $0.12 M | -68.39% |
| 2008-06-30 | $0.38 M | -21.79% |
| 2007-06-30 | $0.49 M | 55.61% |
| 2006-06-30 | $0.31 M | 946.75% |
| 2005-06-30 | $0.03 M | -52.58% |
| 2004-06-30 | $0.06 M | -75.91% |
| 2003-06-30 | $0.26 M | |
| 2001-06-30 | $0.02 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $29.33 B | 3,570,989.42% | 🇺🇸 USA |
 AstraZeneca AZN | $28.62 B | 3,484,548.89% | 🇬🇧 UK |
 Neurocrine Biosciences
NBIX | $0.42 B | 52,056.51% | 🇺🇸 USA |
 MediciNova MNOV | $0.21 M | -73.71% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $6.16 M | 650.57% | 🇺🇸 USA |
 Dicerna Pharmaceuticals DRNA | N/A | N/A | 🇺🇸 USA |
 ANI Pharmaceuticals ANIP | $0.28 B | 34,679.41% | 🇺🇸 USA |
 GlycoMimetics
GLYC | $1.01 M | 23.18% | 🇺🇸 USA |
 Ardelyx ARDX | $55.98 M | 6,715.65% | 🇺🇸 USA |